Picture of Vericel logo

VCEL Vericel Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Vericel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.47-16.7-3.1810.416.5
Depreciation
Non-Cash Items39.741.637.842.745.2
Other Non-Cash Items
Changes in Working Capital-6.15-11.2-3.96-0.45-21.4
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities2917.735.358.251.9
Capital Expenditures-7.92-7.6-27.5-64-27.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.41-28.624.4-15.1-16.8
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-3.5-36.2-3.13-79-43.9
Financing Cash Flow Items-2.01-2.61-2.38-5.46-6.86
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities9.171.043.6219.17.07
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash34.7-17.535.8-1.8215